Tsumura & Co
TSE:4540
Tsumura & Co
Tsumura & Co., a venerable name in the herbal medicine industry, traces its roots back to 1893. Emerging from Japan's rich pharmacopeia tradition, the company has carved a niche by blending age-old herbal knowledge with contemporary research and quality control. This synergy allows Tsumura to thrive in the modern marketplace, offering Kampo—a traditional Japanese herbal medicine—as their primary product line. Tsumura stands out in its meticulous approach to sourcing high-quality raw materials, employing state-of-the-art technology to ensure efficacy and safety. This rigorous quality assurance not only honors the integrity of traditional formulas but also aligns with the stringent standards of modern healthcare.
In its pursuit of growth, Tsumura expertly navigates the delicate balance between tradition and innovation. The company generates revenue through the sale of its Kampo products, which are widely used in clinics and hospitals across Japan, reflecting a significant integration into the mainstream healthcare system. Additionally, Tsumura's strategic collaborations with pharmaceutical companies expand its reach into international markets. Through educational initiatives, they further advocate for the understanding and acceptance of herbal medicine globally. By continually investing in research and development, Tsumura aims to bolster their product offerings, ensuring that the ancient wisdom of Kampo remains relevant in today's fast-paced, health-conscious world.
Earnings Calls
In the face of the ongoing war, the Ukrainian company displayed remarkable resilience. Despite a transformed workforce and operations, it successfully maintained cash flow positivity and responded adeptly to market conditions. Financial results showed improvements, with increased sales volumes and prices leading to boosted revenues and a stronger net cash position. This performance supported significant humanitarian efforts, with $19 million funded towards over 70 projects to aid war efforts, including shelter, food, and medical supplies in partnership with local authorities.
You don't have any saved screeners yet
With the war approaching the middle of its second year, Ukraine continues to demonstrate an incredible resilience. Because of the war, our workforce is very different today and our operations have changed, too, adapting to become more nimble and responsive to different challenges as they develop. I believe that our business is the right size in the current environment. We are able to respond to market conditions and remain cash flow positive.
Our financial performance is testament to the resilience of our workforce. Improvements in sales volumes and prices helped lift revenues, reduce unit costs and increase our net cash position, all whilst continuing to invest in the business.
Indeed, remaining profitable has allowed us to continue our humanitarian support, funding USD 19 million for 70-plus projects and initiatives, including provision of shelter, food and medical supplies, partnering with authorities, and donating equipment and supplies. We are proud of our achievements, and we are ready to play our part in the construction of Ukraine. [Foreign Language].